Skip to content

Industrial Pharmacist

  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy
  • ANDA
  • ADL
  • FRD
  • QbD
  • QA
  • QC
  • RA
  • FDA
  • VS
  • SCM
  • Q&A
  • Dissolution
  • Data Integrity
  • Validation
  • Manufacturing
  • Packaging
  • Microbiology
Industrial Pharmacist
  • HVAC Qualification Process
    Engineering

    HVAC Qualification Process

    Byipharmacist November 3, 2024November 3, 2024

    Design Qualification (DQ) The DQ phase involves verifying that the HVAC system is designed according to the requirements of the facility, production process, and regulatory guidelines (e.g., WHO, EU GMP, FDA). It should ensure that: Room classification: Cleanrooms and controlled environments are designed to meet the required cleanliness level, such as ISO 7 or ISO…

    Read More HVAC Qualification ProcessContinue

  • USFDA Complaint Laboratory KPIs Measurements
    Analytical Development | QC

    USFDA Complaint Laboratory KPIs Measurements

    Byipharmacist November 1, 2024November 1, 2024

    Analytical Laboratory KPIs: Turnaround Time (TAT) Test Completion Rate: Accuracy and Precision: Instrument Uptime: Sample Rejection Rate: Quality Control KPIs: Out-of-Specification (OOS) Rate: Out-of-Trend (OOT) Rate: Deviation Rate: Corrective Action/Preventive Action (CAPA) Effectiveness: Read also: Resource Person: Rajesh Jain

    Read More USFDA Complaint Laboratory KPIs MeasurementsContinue

  • Fishbone Diagram for Root Cause Analysis
    QRM

    Fishbone Diagram for Root Cause Analysis

    Byipharmacist October 31, 2024October 31, 2024

    A fishbone diagram, also known as Ishikawa diagram or cause-and-effect diagram, is a visualization tool used to identify and organize potential causes of a specific problem or effect. It’s called a fishbone diagram because of its shape resembling the skeleton of a fish. Here’s how it works: It’s widely used in problem-solving processes, quality management,…

    Read More Fishbone Diagram for Root Cause AnalysisContinue

  • Lyophilization Process in Pharmaceutical Industry
    Lyophilization

    Lyophilization Process in Pharmaceutical Industry

    Byipharmacist October 28, 2024October 28, 2024

    Freeze drying, or lyophilization, is a critical process in the pharmaceutical industry, primarily used to enhance the stability and shelf life of delicate drugs and biological products. This advanced dehydration method allows for the preservation of pharmaceuticals without compromising their efficacy, making it indispensable for high-quality drug production. Understanding the Lyophilization Process Freezing Phase: Initially…

    Read More Lyophilization Process in Pharmaceutical IndustryContinue

  • PDCA Cycle in Pharmaceutical Industry
    Continuous Improvement

    PDCA Cycle in Pharmaceutical Industry

    Byipharmacist October 28, 2024October 28, 2024

    The Deming PDCA (Plan-Do-Check-Act) cycle is a continuous improvement process that helps organizations systematically solve problems and enhance processes. Let’s break down each phase with the provided format: Plan (P) Problem Analysis Goal (Measurable) Do (D) Check (C) Responsibility Act (A) The PDCA cycle is iterative, and after the “Act” phase, the cycle begins again…

    Read More PDCA Cycle in Pharmaceutical IndustryContinue

  • Operational Excellence Strategies
    Continuous Improvement

    Operational Excellence Strategies

    Byipharmacist October 25, 2024October 25, 2024

    “Operational excellence” refers to a philosophy of continuous improvement in an organization’s processes, systems, and culture to achieve sustainable competitive advantage and superior performance. Here are some strategies commonly associated with achieving operational excellence: Continuous Improvement (Kaizen): Encouraging a culture of constant improvement by empowering employees at all levels to identify and implement small, incremental…

    Read More Operational Excellence StrategiesContinue

  • Regulatory Considerations for RABS Implementation
    Clean Room

    Regulatory Considerations for RABS Implementation

    Byipharmacist October 25, 2024

    Regulators encourage the use of restricted access barrier system (RABS) or isolator technologies. Such settings minimize direct human intervention in a process, reducing the risk of microbial ingress from operators. Transition from a classic design based on grade-A or grade-B cleanrooms to an upgraded facility is not to be taken lightly. Such a project would…

    Read More Regulatory Considerations for RABS ImplementationContinue

  • KAIZEN for Continuous Improvement
    Continuous Improvement

    KAIZEN for Continuous Improvement

    Byipharmacist October 23, 2024October 23, 2024

    Kaizen is a Japanese term meaning change for the better or continuous improvement Kaizen fosters an environment where employees at all levels are continually involved in suggesting and implementing improvements to their workflows. This approach not only increases efficiency and productivity but also instills a sense of ownership and teamwork among employees, encouraging them to…

    Read More KAIZEN for Continuous ImprovementContinue

Page navigation

Previous PagePrevious 1 … 13 14 15 16 17 … 45 Next PageNext

Popular Articles

  • How Expiry Dates Are Determined for Medicines?

    How Expiry Dates Are Determined for Medicines?

  • Difference Between HPLC and UHPLC

    Difference Between HPLC and UHPLC

  • Difference Between ISO Standards and EU GMP Annex 1

    Difference Between ISO Standards and EU GMP Annex 1

  • Titration in Pharmaceutical Industry

    Titration in Pharmaceutical Industry

  • Calculation of Peak Purity in HPLC

    Calculation of Peak Purity in HPLC

  • Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

    Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

  • Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

    Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

  • Audits in the Pharmaceutical Industry | Internal vs External

    Audits in the Pharmaceutical Industry | Internal vs External

  • USFDA Complaint Laboratory KPIs Measurements

    USFDA Complaint Laboratory KPIs Measurements

  • Difference Between Generic ANDA and 505(b)(2) Submissions

    Difference Between Generic ANDA and 505(b)(2) Submissions

  • Difference Between Disinfection and Sterilization

    Difference Between Disinfection and Sterilization

  • Key Elements of an Analytical Worksheet

    Key Elements of an Analytical Worksheet

  • Interview Questions and Answers on GMP

    Interview Questions and Answers on GMP

  • Quality by Design (QbD) and Design Space in Pharmaceutical Development

    Quality by Design (QbD) and Design Space in Pharmaceutical Development

  • CPP and CQA in Different Stages of Drug Product Manufacturing

    CPP and CQA in Different Stages of Drug Product Manufacturing

  • FDA Recall Classification System

    FDA Recall Classification System

  • Analytical Test Method Validation and Verification

    Analytical Test Method Validation and Verification

  • GLP vs GMP vs GCP | Similarities and Differences

    GLP vs GMP vs GCP | Similarities and Differences

  • Pharmaceutical Validation Interview Questions and Answers

    Pharmaceutical Validation Interview Questions and Answers

  • Difference Between Purity and Potency

    Difference Between Purity and Potency

© 2026 Industrial Pharmacist

  • Privacy Policy
  • DMCA
  • Contact Us
Industrial Pharmacist
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy